Financial Ratios Coromandel International Limited
Equities
COROMANDEL
INE169A01031
Agricultural Chemicals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,378.50 INR | +1.39% |
|
+7.74% | +26.52% |
12/06 | Coromandel International Issues Corporate Guarantee for Sengal Subsidiary's Loan | MT |
30/05 | Indian benchmarks end May with gains as investors wait for growth data | RE |
Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 12.45 | 12.67 | 14.26 | 9.21 | 8.71 | |||||
Return on Total Capital | 19.97 | 20.81 | 24.17 | 15.19 | 13.81 | |||||
Return On Equity % | 28.08 | 26.56 | 28.22 | 18.91 | 19.88 | |||||
Return on Common Equity | 28.08 | 26.56 | 28.22 | 18.95 | 20.15 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 31.29 | 25.07 | 20.32 | 24.82 | 25.34 | |||||
SG&A Margin | 3.87 | 3.14 | 2.27 | 3.25 | 3.35 | |||||
EBITDA Margin % | 14.3 | 11.41 | 10.31 | 10.89 | 11.07 | |||||
EBITA Margin % | 13.35 | 10.72 | 9.83 | 10.08 | 10.12 | |||||
EBIT Margin % | 13.34 | 10.71 | 9.82 | 10.05 | 10.07 | |||||
Income From Continuing Operations Margin % | 9.35 | 8 | 6.79 | 7.44 | 8.53 | |||||
Net Income Margin % | 9.35 | 8 | 6.79 | 7.44 | 8.58 | |||||
Net Avail. For Common Margin % | 9.35 | 8 | 6.79 | 7.44 | 8.58 | |||||
Normalized Net Income Margin | 7.87 | 6.59 | 5.67 | 6.12 | 5.93 | |||||
Levered Free Cash Flow Margin | 18.17 | 2.57 | 4.93 | -2.67 | 6.45 | |||||
Unlevered Free Cash Flow Margin | 18.6 | 2.8 | 5.31 | -2.17 | 7.11 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.49 | 1.89 | 2.32 | 1.47 | 1.39 | |||||
Fixed Assets Turnover | 6.84 | 8.92 | 12.42 | 7.93 | 7.41 | |||||
Receivables Turnover (Average Receivables) | 12.42 | 46.65 | 69.37 | 22.25 | 18.37 | |||||
Inventory Turnover (Average Inventory) | 3.69 | 4.57 | 5.84 | 3.67 | 3.83 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.98 | 1.87 | 1.75 | 2.07 | 1.89 | |||||
Quick Ratio | 0.56 | 0.29 | 0.75 | 0.77 | 1.05 | |||||
Operating Cash Flow to Current Liabilities | 1.26 | 0.47 | 0.1 | 0.24 | 0.35 | |||||
Days Sales Outstanding (Average Receivables) | 29.38 | 7.82 | 5.26 | 16.45 | 19.87 | |||||
Days Outstanding Inventory (Average Inventory) | 99 | 79.83 | 62.46 | 99.64 | 95.22 | |||||
Average Days Payable Outstanding | 118.33 | 81.1 | 69.13 | 116.42 | 113.92 | |||||
Cash Conversion Cycle (Average Days) | 10.05 | 6.56 | -1.41 | -0.33 | 1.17 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 7.47 | 6.21 | 4.96 | 5.21 | 6.95 | |||||
Total Debt / Total Capital | 6.95 | 5.85 | 4.73 | 4.95 | 6.5 | |||||
LT Debt/Equity | 7.03 | 5.83 | 4.59 | 4.34 | 5.34 | |||||
Long-Term Debt / Total Capital | 6.54 | 5.49 | 4.37 | 4.13 | 4.99 | |||||
Total Liabilities / Total Assets | 42.1 | 43.66 | 44.45 | 40.4 | 40.71 | |||||
EBIT / Interest Expense | 19.28 | 30.16 | 16.24 | 12.58 | 9.63 | |||||
EBITDA / Interest Expense | 21.04 | 32.7 | 17.26 | 13.88 | 10.78 | |||||
(EBITDA - Capex) / Interest Expense | 19.13 | 28.6 | 13.88 | 10.89 | 7.4 | |||||
Total Debt / EBITDA | 0.19 | 0.18 | 0.13 | 0.2 | 0.29 | |||||
Net Debt / EBITDA | -0.15 | -0.14 | -0.32 | -0.51 | -1.32 | |||||
Total Debt / (EBITDA - Capex) | 0.2 | 0.2 | 0.16 | 0.26 | 0.42 | |||||
Net Debt / (EBITDA - Capex) | -0.16 | -0.16 | -0.4 | -0.65 | -1.93 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 8.2 | 34.75 | 55.03 | -25.55 | 9.19 | |||||
Gross Profit, 1 Yr. Growth % | 10.7 | 8.49 | 25.71 | -9.07 | 11.46 | |||||
EBITDA, 1 Yr. Growth % | 11.51 | 8.96 | 40.03 | -21.34 | 10.99 | |||||
EBITA, 1 Yr. Growth % | 11.46 | 9.72 | 42.19 | -23.62 | 9.55 | |||||
EBIT, 1 Yr. Growth % | 11.5 | 9.71 | 42.25 | -23.87 | 9.42 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 24.8 | 15 | 31.7 | -18.5 | 25.24 | |||||
Net Income, 1 Yr. Growth % | 24.8 | 15 | 31.7 | -18.42 | 25.84 | |||||
Normalized Net Income, 1 Yr. Growth % | 29.28 | 14.61 | 33.43 | -19.64 | 5.87 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 24.54 | 14.95 | 31.55 | -18.47 | 25.78 | |||||
Accounts Receivable, 1 Yr. Growth % | -68.03 | -52.23 | 122.48 | 136.49 | -11.8 | |||||
Inventory, 1 Yr. Growth % | -3.57 | 40.85 | 20.56 | 4.44 | 3.41 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 0.35 | 5.84 | 16.5 | 16.62 | 17.26 | |||||
Total Assets, 1 Yr. Growth % | -12.35 | 26.86 | 26.14 | 11.36 | 19.41 | |||||
Tangible Book Value, 1 Yr. Growth % | 19.38 | 23.44 | 24.43 | 15.13 | 10.99 | |||||
Common Equity, 1 Yr. Growth % | 19.29 | 23.45 | 24.37 | 19.12 | 17.71 | |||||
Cash From Operations, 1 Yr. Growth % | 122.89 | -49.93 | -71.56 | 141.58 | 72.56 | |||||
Capital Expenditures, 1 Yr. Growth % | -26.5 | 47.66 | 117.77 | -12.95 | 61.45 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 98.13 | -80.81 | 197.14 | -140.23 | 27.9 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 82.82 | -79.64 | 194.52 | -130.37 | 29.15 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 0 | 0 | -50 | 100 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.67 | 20.61 | 44.54 | 7.44 | -9.84 | |||||
Gross Profit, 2 Yr. CAGR % | 7.85 | 9.2 | 16.78 | 6.91 | 0.67 | |||||
EBITDA, 2 Yr. CAGR % | 12.79 | 9.37 | 23.52 | 4.95 | -6.56 | |||||
EBITA, 2 Yr. CAGR % | 12.99 | 9.66 | 24.9 | 4.21 | -8.53 | |||||
EBIT, 2 Yr. CAGR % | 13.05 | 9.68 | 24.93 | 4.07 | -8.73 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 35.82 | 19.8 | 23.06 | 3.6 | 1.03 | |||||
Net Income, 2 Yr. CAGR % | 35.82 | 19.8 | 23.06 | 3.65 | 1.32 | |||||
Normalized Net Income, 2 Yr. CAGR % | 26.23 | 20.65 | 23.66 | 3.55 | -7.77 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 35.58 | 19.65 | 22.97 | 3.56 | 1.26 | |||||
Accounts Receivable, 2 Yr. CAGR % | -44.87 | -60.92 | 3.1 | 129.37 | 44.42 | |||||
Inventory, 2 Yr. CAGR % | -10.42 | 16.54 | 30.31 | 12.21 | 3.92 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 18.74 | 3.05 | 11.04 | 16.56 | 16.94 | |||||
Total Assets, 2 Yr. CAGR % | -8.28 | 5.45 | 26.5 | 18.52 | 15.31 | |||||
Tangible Book Value, 2 Yr. CAGR % | 24 | 21.39 | 23.93 | 19.69 | 13.04 | |||||
Common Equity, 2 Yr. CAGR % | 23.84 | 21.35 | 23.91 | 21.72 | 18.41 | |||||
Cash From Operations, 2 Yr. CAGR % | 180.78 | 5.64 | -62.26 | -17.11 | 104.18 | |||||
Capital Expenditures, 2 Yr. CAGR % | -16.97 | 4.18 | 79.32 | 37.69 | 18.55 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 234.5 | -38.58 | -24.49 | 9.33 | 3.12 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 478.77 | -39.22 | -22.57 | -5.42 | 4.3 | |||||
Dividend Per Share, 2 Yr. CAGR % | 35.87 | 0 | 0 | -29.29 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 8.65 | 13.06 | 31.14 | 15.86 | 8.02 | |||||
Gross Profit, 3 Yr. CAGR % | 9.14 | 7.8 | 14.45 | 7.44 | 8.41 | |||||
EBITDA, 3 Yr. CAGR % | 15.75 | 10.92 | 18.76 | 6.27 | 6.93 | |||||
EBITA, 3 Yr. CAGR % | 16.06 | 11.26 | 19.58 | 6.02 | 5.96 | |||||
EBIT, 3 Yr. CAGR % | 16.11 | 11.3 | 19.61 | 5.92 | 5.82 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 24.35 | 28.49 | 23.64 | 7.27 | 10.37 | |||||
Net Income, 3 Yr. CAGR % | 24.35 | 28.49 | 23.64 | 7.3 | 10.58 | |||||
Normalized Net Income, 3 Yr. CAGR % | 19.75 | 21.51 | 24.77 | 7.11 | 4.32 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 24.22 | 28.32 | 23.49 | 7.23 | 10.49 | |||||
Accounts Receivable, 3 Yr. CAGR % | -29.43 | -47.44 | -30.22 | 35.96 | 66.8 | |||||
Inventory, 3 Yr. CAGR % | 4.76 | 4.16 | 17.87 | 21.04 | 9.2 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 15.44 | 14.27 | 7.36 | 12.87 | 16.79 | |||||
Total Assets, 3 Yr. CAGR % | -3.33 | 2.19 | 11.94 | 21.24 | 18.81 | |||||
Tangible Book Value, 3 Yr. CAGR % | 21.28 | 23.81 | 22.4 | 20.92 | 16.72 | |||||
Common Equity, 3 Yr. CAGR % | 21.15 | 23.71 | 22.35 | 22.29 | 20.37 | |||||
Cash From Operations, 3 Yr. CAGR % | 150.74 | 58.04 | -31.79 | -29.93 | 5.84 | |||||
Capital Expenditures, 3 Yr. CAGR % | 15.23 | 0.59 | 33.2 | 40.93 | 45.19 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 97.88 | 28.68 | 3.88 | -38.78 | 46.74 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 81.98 | 89.15 | 2.85 | -43.32 | 47.42 | |||||
Dividend Per Share, 3 Yr. CAGR % | 22.68 | 22.68 | 0 | -20.63 | 0 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 4.36 | 13.76 | 21.73 | 10.77 | 12.89 | |||||
Gross Profit, 5 Yr. CAGR % | 10.37 | 10.84 | 11.98 | 7.45 | 8.72 | |||||
EBITDA, 5 Yr. CAGR % | 15.73 | 14.98 | 18.43 | 8.49 | 7.9 | |||||
EBITA, 5 Yr. CAGR % | 16.76 | 15.7 | 19.12 | 8.39 | 7.43 | |||||
EBIT, 5 Yr. CAGR % | 16.79 | 15.76 | 19.16 | 8.35 | 7.35 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 30.04 | 26.23 | 23.83 | 17.89 | 14.05 | |||||
Net Income, 5 Yr. CAGR % | 30.04 | 26.23 | 23.83 | 17.91 | 14.18 | |||||
Normalized Net Income, 5 Yr. CAGR % | 28.7 | 23.21 | 20.87 | 13.98 | 10.57 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 29.85 | 26.04 | 23.72 | 17.78 | 14.07 | |||||
Accounts Receivable, 5 Yr. CAGR % | -19.52 | -30.4 | -17.88 | -5.25 | -6.65 | |||||
Inventory, 5 Yr. CAGR % | 2.09 | 16.26 | 14.31 | 7.31 | 12.08 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 9.2 | 10.63 | 13.66 | 15.18 | 11.09 | |||||
Total Assets, 5 Yr. CAGR % | -0.63 | 5.47 | 7.65 | 8.43 | 13.28 | |||||
Tangible Book Value, 5 Yr. CAGR % | 14.43 | 17.13 | 22.33 | 22.14 | 18.57 | |||||
Common Equity, 5 Yr. CAGR % | 14.35 | 17.08 | 22.25 | 22.91 | 20.76 | |||||
Cash From Operations, 5 Yr. CAGR % | 195.63 | 17.82 | 17.55 | 22.09 | 5.76 | |||||
Capital Expenditures, 5 Yr. CAGR % | 11.84 | 25.35 | 37.53 | 14.05 | 27.14 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 46.64 | -0.7 | 34.39 | 20.56 | 3.58 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 60.74 | -3.73 | 29.1 | 43.35 | 3.42 | |||||
Dividend Per Share, 5 Yr. CAGR % | 24.57 | 19.14 | 13.05 | -1.59 | 0 |
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition